93M1 Stock Overview
An investment company, engages in the healthcare business in Germany. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
MPH Health Care AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €22.40 |
| 52 Week High | €36.20 |
| 52 Week Low | €15.90 |
| Beta | 1.14 |
| 1 Month Change | -7.44% |
| 3 Month Change | -12.50% |
| 1 Year Change | 38.70% |
| 3 Year Change | 6.67% |
| 5 Year Change | -42.71% |
| Change since IPO | -3.54% |
Recent News & Updates
MPH Health Care's (FRA:93M1) Profits Appear To Have Quality Issues
Oct 17
MPH Health Care AG (FRA:93M1) Held Back By Insufficient Growth Even After Shares Climb 28%
Sep 06Recent updates
MPH Health Care's (FRA:93M1) Profits Appear To Have Quality Issues
Oct 17MPH Health Care AG (FRA:93M1) Held Back By Insufficient Growth Even After Shares Climb 28%
Sep 06MPH Health Care AG (FRA:93M1) Held Back By Insufficient Growth Even After Shares Climb 30%
Jun 13Shaky Earnings May Not Tell The Whole Story For MPH Health Care (FRA:93M1)
Sep 15A Look At The Fair Value Of MPH Health Care AG (FRA:93M1)
Sep 02We're Interested To See How MPH Health Care (FRA:93M1) Uses Its Cash Hoard To Grow
Oct 02We're Not Worried About MPH Health Care's (FRA:93M1) Cash Burn
Jun 19Shareholder Returns
| 93M1 | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | -5.1% | -2.5% | -2.6% |
| 1Y | 38.7% | -15.6% | 6.9% |
Return vs Industry: 93M1 exceeded the German Pharmaceuticals industry which returned -15.2% over the past year.
Return vs Market: 93M1 exceeded the German Market which returned 7.1% over the past year.
Price Volatility
| 93M1 volatility | |
|---|---|
| 93M1 Average Weekly Movement | 5.3% |
| Pharmaceuticals Industry Average Movement | 5.4% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.3% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 93M1 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 93M1's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 2 | Patrick Brenske | www.mph-ag.de |
MPH Health Care AG, an investment company, engages in the healthcare business in Germany. The company operates Beauty, Pharma, and Real Estate segments. It offers medicalaesthetic beauty operations and treatments, as well as the operation and provision of medical infrastructures for partner companies; and pharmaceuticals and medical products in the therapeutic areas of oncology, HIV/AIDS, neurology, rheumatology, other chronic diseases, and aesthetic medicine.
MPH Health Care AG Fundamentals Summary
| 93M1 fundamental statistics | |
|---|---|
| Market cap | €98.47m |
| Earnings (TTM) | €119.48m |
| Revenue (TTM) | €118.24m |
0.8x
P/E Ratio0.8x
P/S RatioIs 93M1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 93M1 income statement (TTM) | |
|---|---|
| Revenue | €118.24m |
| Cost of Revenue | €0 |
| Gross Profit | €118.24m |
| Other Expenses | -€1.23m |
| Earnings | €119.48m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Apr 30, 2025
| Earnings per share (EPS) | 27.91 |
| Gross Margin | 100.00% |
| Net Profit Margin | 101.04% |
| Debt/Equity Ratio | 2.6% |
How did 93M1 perform over the long term?
See historical performance and comparisonDividends
5.4%
Current Dividend Yield4%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 17:54 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
MPH Health Care AG is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Edward Acklin | First Berlin Equity Research GmbH |
| Cosmin Filker | GBC AG |
| Thomas Wissler | Hauck Aufhäuser Investment Banking |